Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Bayer EUR 1.62B 529M 2026-09
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Cytokinetics USD -160.3M 9.02M 2026-06
Eisai JPY 25.94B 8.21B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Genmab DKK 401M 186M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
MacroGenics USD -64.54M 34.34M 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -687M 571M 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 6.66B 4.99B 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Xencor USD 25.1M 59.73M 2026-09